| CELZ Stock | | | USD 2.44 0.13 5.63% |
President
Mr. Donald Dickerson is Chief Financial Officer, Senior Vice President, Director of the Company. Mr. Dickerson has served as a director and as Chief Financial Officer and Senior VicePresident of CMT since February 2016, and has served as a director and as Vice President and Chief Operating Officer of Creative Medical Health since June 2014. He received his Masters of Business Administration in Finance from the University of Southern California in May 2002. Mr. Dickerson has worked in a number of management and accounting positions and has experience with companies in the technology, manufacturing and health sciences area. From October 2003 until February 2009 he was employed as a vicepresident for JP Morgan Chase in finance from March 2009 until May 2014 he served as a director for GMT Ventures in finance and operations and from June 2011 until May 2014 he also served as CFO for Medistem, Inc. in finance. since 2016.
| Age | 59 |
| Tenure | 9 years |
| Address | 211 East Osborn Road, Phoenix, AZ, United States, 85012 |
| Phone | (480) 399-2822 |
| Web | https://www.creativemedicaltechnology.com |
Creative Medical Management Efficiency
The company has return on total asset
(ROA) of
(0.3627) % which means that it has lost $0.3627 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity
(ROE) of
(0.5703) %, meaning that it created substantial loss on money invested by shareholders. Creative Medical's management efficiency ratios could be used to measure how well Creative Medical manages its routine affairs as well as how well it operates its assets and liabilities.
Return On Tangible Assets is likely to drop to -0.62 in 2025.
Return On Capital Employed is likely to drop to -0.51 in 2025. At this time, Creative Medical's
Total Assets are fairly stable compared to the past year.
Total Current Assets is likely to rise to about 12.4
M in 2025, whereas
Non Current Assets Total are likely to drop slightly above 401.4
K in 2025.
Creative Medical Technology currently holds 14.19
K in liabilities. Creative Medical Tec has a current ratio of 57.7, suggesting that it is
liquid enough and is able to pay its financial obligations when due. Note, when we think about Creative Medical's use of debt, we should always consider it together with its cash and equity.
Similar Executives
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona. Creative Medical operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people. Creative Medical Technology (CELZ) is traded on NASDAQ Exchange in USA. It is located in 211 East Osborn Road, Phoenix, AZ, United States, 85012 and employs 4 people. Creative Medical is listed under Biotechnology category by Fama And French industry classification.
Management Performance
Creative Medical Tec Management Team
Elected by the shareholders, the Creative Medical's board of directors comprises two types of representatives: Creative Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Creative. The board's role is to monitor Creative Medical's management team and ensure that shareholders' interests are well served. Creative Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Creative Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Creative Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Creative Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Creative Stock Analysis
When running Creative Medical's price analysis, check to
measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to
predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.